AAIC 2025 Abstract

Blood‐Based Clinical Markers for Early Dementia Detection: Insights from AD‐DETECT‐Cohort

Study in peopleBiomarkers

Abstract

Background: Over 55 million people worldwide live with dementia, with more than 60% residing in low‐ and middle‐income countries. Alzheimer's disease, the most common form of dementia, accounts for 60–70% of cases. Early and accurate diagnosis remains a global challenge, necessitating novel approaches to mitigate the disease burden.

The paper